Risk Factors, Prevention, and Management of Postoperative Recurrence After Resection of Hepatocellular Carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Surgery
Reference161 articles.
1. Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
2. Hepatectomy for Hepatocellular Carcinoma: Toward Zero Hospital Deaths
3. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections
Cited by 711 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives;Hepatobiliary Surgery and Nutrition;2024-02
2. Resection Versus Transplant for Hepatocellular Carcinoma;Surgical Clinics of North America;2024-02
3. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation;Meditsinskiy sovet = Medical Council;2024-01-17
4. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis;Frontiers in Immunology;2024-01-08
5. Functional Enrichment Analysis of Tumor Microenvironment–Driven Molecular Alterations That Facilitate Epithelial-to-Mesenchymal Transition and Distant Metastasis;Bioinformatics and Biology Insights;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3